$2.96 Billion is the total value of Avoro Capital Advisors LLC's 43 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 155.6% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Buy | MIRATI THERAPEUTICS INC | $316,143,000 | -36.3% | 4,112,700 | +6.8% | 10.67% | -26.8% |
| IOVA | Buy | IOVANCE BIOTHERAPEUTICS INC | $269,727,000 | +10.4% | 9,010,413 | +2.1% | 9.10% | +26.9% |
| HZNP | Buy | HORIZON THERAPEUTICS PLC | $135,512,000 | -6.4% | 4,575,000 | +14.4% | 4.57% | +7.6% |
| KPTI | Buy | KARYOPHARM THERAPEUTICS INC | $134,470,000 | +18.9% | 7,000,000 | +18.6% | 4.54% | +36.7% |
| DCPH | Buy | DECIPHERA PHARMACEUTICALS INC | $82,340,000 | +164.6% | 2,000,000 | +300.0% | 2.78% | +204.0% |
| XLRN | New | ACCELERON PHARMA INC | $77,288,000 | – | 860,000 | +100.0% | 2.61% | – |
| ADVM | Buy | ADVERUM BIOTECHNOLOGIES INC | $69,856,000 | +15.5% | 7,150,000 | +36.2% | 2.36% | +32.8% |
| ZGNX | Buy | ZOGENIX INC | $69,244,000 | -33.6% | 2,800,000 | +40.0% | 2.34% | -23.7% |
| PTCT | New | PTC THERAPEUTICS INC | $53,532,000 | – | 1,200,000 | +100.0% | 1.81% | – |
| RLMD | New | RELMADA THERAPEUTICS INC | $39,227,000 | – | 1,150,000 | +100.0% | 1.32% | – |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $34,663,000 | – | 4,365,655 | +100.0% | 1.17% | – |
| XENE | Buy | XENON PHARMACEUTICALS INC | $31,434,000 | -0.1% | 2,772,000 | +15.5% | 1.06% | +14.8% |
| SAGE | New | SAGE THERAPEUTICS INC | $28,720,000 | – | 1,000,000 | +100.0% | 0.97% | – |
| AUPH | New | AURINIA PHARMACEUTICALS INC | $25,030,000 | – | 1,725,000 | +100.0% | 0.84% | – |
| New | TRILLIUM THERAPEUTICS INC | $19,998,000 | – | 4,950,000 | +100.0% | 0.68% | – | |
| BDTX | New | BLACK DIAMOND THERAPEUTICS INC | $13,018,000 | – | 521,750 | +100.0% | 0.44% | – |
| RVMD | New | REVOLUTION MEDICINES INC | $9,860,000 | – | 450,000 | +100.0% | 0.33% | – |
| AMRN | Buy | AMARIN CORP PLCsponsored adr | $8,000,000 | -80.4% | 2,000,000 | +5.3% | 0.27% | -77.4% |
| AGEN | New | AGENUS INC | $6,738,000 | – | 2,750,000 | +100.0% | 0.23% | – |
| IMGN | New | IMMUNOGEN INC | $6,479,000 | – | 1,900,000 | +100.0% | 0.22% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $6,126,000 | – | 145,000 | +100.0% | 0.21% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INCcall | $3,125,000 | – | 1,250,000 | +100.0% | 0.10% | – |
| AMRN | New | AMARIN CORP PLCcall | $10,000 | – | 1,000,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 36 | Q3 2023 | 17.9% |
| MIRATI THERAPEUTICS INC. | 35 | Q3 2023 | 17.2% |
| BIOMARIN PHARMACEUTICAL INC | 31 | Q3 2023 | 8.0% |
| SAREPTA THERAPUTICS INC | 28 | Q3 2023 | 14.8% |
| ASCENDIS PHARMA | 28 | Q3 2023 | 9.1% |
| ARGENX SE | 26 | Q3 2023 | 9.5% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
| FENNEC PHARMACEUTICALS INC | 25 | Q3 2023 | 0.4% |
| MADRIGAL PHARMACEUTICALS INC | 22 | Q3 2023 | 7.2% |
| XENON PHARMACEUTICALS INC | 22 | Q3 2023 | 3.3% |
View Avoro Capital Advisors LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adverum Biotechnologies, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| DICE Therapeutics, Inc. | February 14, 2023 | 2,525,555 | 5.3% |
| IOVANCE BIOTHERAPEUTICS, INC. | February 14, 2023 | 7,020,000 | 4.4% |
| IVERIC bio, Inc. | February 14, 2023 | 6,750,000 | 5.0% |
| Kura Oncology, Inc. | February 14, 2023 | 3,105,000 | 4.5% |
| Aadi Bioscience, Inc. | September 26, 2022 | 2,849,402 | 11.7% |
| ARENA PHARMACEUTICALS INC | February 11, 2022 | 1,235,000 | 2.0% |
| AVADEL PHARMACEUTICALS PLC | February 11, 2022 | 1,670,000 | 2.9% |
| FENNEC PHARMACEUTICALS INC. | February 11, 2022 | 1,200,000 | 4.6% |
| POINT Biopharma Global Inc.Sold out | February 11, 2022 | 0 | 0.0% |
View Avoro Capital Advisors LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-04-23 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Avoro Capital Advisors LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.